References
- Sacandinavian Simvastatin Survival Study (4S). Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease. Lancet 1994;344:1383-9.
- Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med 1995;333:1301-7. https://doi.org/10.1056/NEJM199511163332001
- Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med 1996;335:1001-9. https://doi.org/10.1056/NEJM199610033351401
- Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) Study Group. Prevention of cardiovascular events and death with pravastatin in patients of coronary heart disease and a board range of initial cholesterol levels. N Engl J Med 1998;339:1349-57. https://doi.org/10.1056/NEJM199811053391902
- Hong YJ, Jeong MH, Lim JH, et al. The prognostic significance of statin therapy according to the level of C-reactive protein in acute myocardial infarction patients who underwent percutaneous coronary intervention. Korean Circ J 2003;33:891-900.
- Ridker PM, Danielson E, Fonseca FA, et al. Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial. Lancet 2009;373:1175-82. https://doi.org/10.1016/S0140-6736(09)60447-5
- Schwartz GG, Olsson AG, Ezekowitz MD, et al. Effects of atorvasta-tin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial. JAMA 2001;285: 1711-8. https://doi.org/10.1001/jama.285.13.1711
- Ray KK, Cannon CP, McCabe CH, et al. Early and late benefits of high-dose atorvastatin in patients with acute coronary syndromes: results from the PROVE IT-TIMI 22 trial. J Am Coll Cardiol 2005; 46:1405-10. https://doi.org/10.1016/j.jacc.2005.03.077
- Patti G, Pasceri V, Colonna G, et al. Atorvastatin pretreatment improves outcomes in patients with acute coronary syndromes undergoing early percutaneous coronary intervention: results of the ARMYDA-ACS randomized trial. J Am Coll Cardiol 2007;49:1272-8. https://doi.org/10.1016/j.jacc.2007.02.025
- Yun KH, Jeong MH, Oh SK, et al. The beneficial effect of high loading dose of rosuvastatin before percutaneous coronary intervention in patients with acute coronary syndrome. Int J Cardiol 2009;137:246-51. https://doi.org/10.1016/j.ijcard.2008.06.055
- Ishii H, Ichimiya S, Kanashiro M, et al. Effects of receipt of chronic statin therapy before the onset of acute myocardial infarction: a retrospective study in patients undergoing primary percutaneous coronary intervention. Clin Ther 2006;28:1812-9. https://doi.org/10.1016/j.clinthera.2006.11.003
- Chang SM, Yazbek N, Lakkis NM. Use of statins prior to percutaneous coronary intervention reduces myonecrosis and improves clinical outcome. Catheter Cardiovasc Interv 2004;62:193-7. https://doi.org/10.1002/ccd.20078
- Di Sciascio G, Patti G, Pasceri V, Gaspardone A, Colonna G, Montinaro A. Efficacy of atorvastatin reload in patients on chronic statin th-erapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (Atorvastatin for Reduction of Myocardial Da-mage During Angioplasty) Randomized Trial. J Am Coll Cardiol 2009; 54:558-65. https://doi.org/10.1016/j.jacc.2009.05.028
- Briguori C, Colombo A, Airoldi F, et al. Statin administration before percutaneous coronary intervention: impact on periprocedural myocar-dial infarction. Eur Heart J 2004;25:1822-8. https://doi.org/10.1016/j.ehj.2004.07.017
- Chan AW, Bhatt DL, Chew DP, et al. Relation of inflammation and benefit of statins after percutaneous coronary interventions. Circulation 2003;107:1750-6. https://doi.org/10.1161/01.CIR.0000060541.18923.E9
- Ebrahimi R, Saleh J, Toggart E, et al. Effect of preprocedural statin use on procedural myocardial infarction and major cardiac adverse events in percutaneous coronary intervention: a meta-analysis. J Invasive Cardiol 2008;20:292-5.
- Spencer FA, Allegrone J, Goldberg RJ, et al. Association of statin therapy with outcomes of acute coronary syndromes: the GRACE study. Ann Intern Med 2004;140:857-66. https://doi.org/10.7326/0003-4819-140-11-200406010-00006
- Bauer T, Bohm M, Zahn R, et al. Effect of chronic statin pretreatment on hospital outcome in patients with acute non-ST-elevation myocardial infarction. J Cardiovasc Pharmacol 2009;53:132-6. https://doi.org/10.1097/FJC.0b013e3181976a3c
- Takemoto M, Liao JK. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. Arterioscler Thromb Vasc Biol 2001;21:1712-9. https://doi.org/10.1161/hq1101.098486
- Sposito AC, Chapman MJ. Statin therapy in acute coronary syndromes: mechanistic insight into clinical benefit. Arterioscler Thromb Vasc Biol 2002;22:1524-34. https://doi.org/10.1161/01.ATV.0000032033.39301.6A
- Rhee SJ, Yun KH, Oh SK, et al. Changes of C-reactive protein are associated with myocardial injury after successful percutaneous coronary intervention. Korean Circ J 2008;38:135-9. https://doi.org/10.4070/kcj.2008.38.3.135
- Choi SY, Yang HM, Tahk SJ, et al. Preprocedural hs-CRP level serves as a marker for procedure-related myocardial injury during coronary stenting. Korean Circ J 2005;35:140-8. https://doi.org/10.4070/kcj.2005.35.2.140
- Yun KH, Jeong MH, Oh SK, et al. Response of high-sensitivity C-reactive protein to percutaneous coronary intervention in patients with acute coronary syndrome. Heart Vessels 2009;24:175-80. https://doi.org/10.1007/s00380-008-1110-5
Cited by
- Current Statin Usage for Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Multicenter Survey in Korea vol.35, pp.11, 2012, https://doi.org/10.1002/clc.22038
- Impact of Statin Use Before the Onset of Acute Myocardial Infarction on Coronary Plaque Morphology of the Culprit Lesion vol.64, pp.5, 2011, https://doi.org/10.1177/0003319712449196
- Reduced Left Ventricular Ejection Fraction Is a Risk Factor for In-Hospital Mortality in Patients after Percutaneous Coronary Intervention: A Hospital-Based Survey vol.2018, pp.None, 2011, https://doi.org/10.1155/2018/8753176
- Statin therapy in patients with high and very high cardiovascular risk: an optimal approach vol.19, pp.5, 2011, https://doi.org/10.15829//1728-8800-2020-2696